$4.53
Soligenix is a biotechnology business based in the US. Soligenix shares (SNGX) are listed on the NASDAQ and all prices are listed in US Dollars. Soligenix employs 13 staff and has a trailing 12-month revenue of around $699,210.
Our top picks for where to buy Soligenix stock
How to buy Soligenix stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SNGX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Latest updates for Soligenix
July 11, 2024: Soligenix stock blasted up by over 230% due to the release of new study data showing positive results for its treatement of early-stage cutaneous T-cell lymphoma (CTCL).
Buy Soligenix stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Soligenix stock price (NASDAQ: SNGX)
Use our graph to track the performance of SNGX stocks over time.Soligenix shares at a glance
Latest market close | $4.45 |
---|---|
52-week range | $1.83 - $19.20 |
50-day moving average | $4.81 |
200-day moving average | $6.06 |
Wall St. target price | $41.50 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-9.76 |
Is it a good time to buy Soligenix stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Soligenix price performance over time
Historical closes compared with the close of $4.45 from 2024-07-25
1 week (2024-07-19) | -26.69% |
---|---|
1 month (2024-06-27) | 67.92% |
3 months (2024-04-26) | 972.29% |
6 months (2024-01-26) | 629.63% |
1 year (2023-07-27) | 606.35% |
---|---|
2 years (2022-07-27) | 405.68% |
3 years (2021-07-27) | 354.08% |
5 years (2019-07-26) | 319.81% |
Soligenix financials
Revenue TTM | $699,210 |
---|---|
Gross profit TTM | $95,628 |
Return on assets TTM | -50% |
Return on equity TTM | -23783.76% |
Profit margin | 0% |
Book value | $1.17 |
Market Capitalization | $6 million |
TTM: trailing 12 months
Soligenix share dividends
We're not expecting Soligenix to pay a dividend over the next 12 months.
Have Soligenix's shares ever split?
Soligenix's shares were split on a 1:16 basis on 5 June 2024. So if you had owned 16 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Soligenix shares – just the quantity. However, indirectly, the new 1500% higher share price could have impacted the market appetite for Soligenix shares which in turn could have impacted Soligenix's share price.
Soligenix share price volatility
Over the last 12 months, Soligenix's shares have ranged in value from as little as $1.8301 up to $19.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Soligenix's is 1.874. This would suggest that Soligenix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Soligenix overview
Soligenix, Inc. , a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX302, an IDR technology which is in Phase IIa study to treat mil-to-moderate Psoriasis; and SGX945 and IDR technology that is in Phase IIa protocol for the treatment of Aphthous Ulcers in Behçet's Disease. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia, Ib, and Ic clinical trials; SGX943, a therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc.
Frequently asked questions
What percentage of Soligenix is owned by insiders or institutions?Currently 0.067% of Soligenix shares are held by insiders and 2.546% by institutions. How many people work for Soligenix?
Latest data suggests 13 work at Soligenix. When does the fiscal year end for Soligenix?
Soligenix's fiscal year ends in December. Where is Soligenix based?
Soligenix's address is: 29 Emmons Drive, Princeton, NJ, United States, 08540 What is Soligenix's ISIN number?
Soligenix's international securities identification number is: US8342233074 What is Soligenix's CUSIP number?
Soligenix's Committee on Uniform Securities Identification Procedures number is: 834223109
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question